Harvard Bioscience Inc

HBIONASDAQUSD
7.58 USD
0.03 (0.40%)AT CLOSE (11:59 AM EDT)
7.51
0.07 (0.92%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
7.51
0.07 (0.92%)
🟢Market: OPEN

Harvard Bioscience Inc (HBIO) is currently trading at $7.51. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics suggest HBIO is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Aug 25, 2026.

Open?$7.36
High?$7.58
Low?$7.36
Prev. Close?$7.55
Volume?6.1K
Avg. Volume?18.0K
VWAP?$7.50
Rel. Volume?0.34x
Bid / Ask
Bid?$6.12 × 100
Ask?$8.78 × 100
Spread?$2.66
Midpoint?$7.45
Valuation & Ratios
Market Cap?34.4M
Shares Out?4.6M
Float?3.4M
Float %?74.3%
P/E Ratio?N/A
P/B Ratio?4.63
EPS?-$2.29
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.
Employees
339
Market Cap
34.4M
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Listed
2000-12-07
Address
84 OCTOBER HILL RD
HOLLISTON, MA 01746
Phone: (508) 893-8999
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+2/3)
Short-Term (Ripple)? Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
80
Short Sent.?
64
Piotroski F-Score?2/9Weak
Altman Z-Score?-2.28Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.76%Low
Short Interest?58.8K
Days to Cover?2.6
Free Float3.4M
Avg Daily Volume22.2K
Settlement Date2026-08-14
Financial Health
Current Ratio?1.87Adequate
Quick Ratio?0.98Weak
Cash Ratio?0.26Low
Debt/Equity?4.94High
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A
P/B?
Peers
100
S&P
39
4.63FAIR
P/S?
Peers
100
S&P
97
0.39CHEAP
P/FCF?
N/A
EV/EBITDA?
Peers
100
S&P
65
12.5FAIR
EV/Sales?
Peers
100
S&P
97
0.74CHEAP
Returns & Efficiency
ROE?
S&P
3
-140.4%WEAK
ROA?
S&P
3
-13.7%WEAK
Cash Flow & Enterprise
FCF?$-1119000
Enterprise Value?$64.5M
Fundamentals ratios updated end of day